Are There Any Emerging Trends or Research in Antitumor Antibiotics?
Recent research is focused on minimizing the adverse effects of antitumor antibiotics while enhancing their efficacy. Innovations include the development of liposomal formulations of drugs like doxorubicin, which help reduce cardiotoxicity. Additionally, researchers are exploring combination therapies with other chemotherapeutic agents or targeted therapies to improve outcomes. There is also interest in biomarker-driven approaches to identify patients who are most likely to benefit from these treatments.
